Copies of the Tender Offer Documents may be obtained from D.F. to act as the Dealer Manager in connection with the Tender Offer. The Issuer has retained BNP Paribas Securities Corp. The complete terms and conditions of the Tender Offer are set forth in the Offer to Purchase, dated J(the " Offer to Purchase"), and in the related notice of guaranteed delivery (the " Notice of Guaranteed Delivery" and, together with the Offer to Purchase, the " Tender Offer Documents"), along with any amendments and supplements thereto, which holders are urged to read carefully before making any decision with respect to the Tender Offer. The Tender Offer is conditioned upon satisfaction of certain conditions, but is not conditioned upon any minimum amount of Notes being tendered. The Issuer expects to pay the applicable consideration for Notes validly tendered and not validly withdrawn at or prior to the Expiration Time on June 16, 2023, the third business day following the Expiration Time (the " Settlement Date").
The guaranteed delivery date is expected to be June 15, 2023. Holders who have validly tendered their Notes may withdraw such Notes at any time at or prior to the Expiration Time. The Tender Offer will expire at 5:00 p.m., New York City time, on June 13, 2023, unless extended or earlier terminated (the " Expiration Time"). In addition to the consideration, holders will also receive accrued and unpaid interest on the Notes, if any, from the last interest payment date up to, but excluding, the Settlement Date (as defined below).
#DISCOVERY INC BENEFITS UPDATE#
Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.(1) Per $1,000 principal amount of Notes validly tendered before the Expiration Time (as defined below), not validly withdrawn and accepted for purchase. The company assumes no duty to update the information to reflect subsequent developments. The information contained in this website was current as of the date presented.
Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (No Duty to Update
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Risks and uncertainties include, but are not limited to, general industry conditions and competition general economic factors, including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally global trends toward healthcare cost containment technological advances, new products and patents attained by competitors challenges inherent in new product development, including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation, including patent litigation, and/or regulatory actions. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Worldwide Countries outside of the United States and Canada.įorward-Looking Statement Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA.We are known as Merck & Co., Inc., Rahway, New Jersey, USA in the United States, Canada & Puerto Rico. We are one company, but we operate under two different corporate brand names.
0 kommentar(er)
